Changchun
Xiu Xiu Pharmaceutical Group is a large-scale modern private enterprise integrating scientific research, production and marketing. The group headquarters is located in Changchun and the marketing headquarters is located in Beijing. The industrial layout has extended from Tonghua, a famous medical city, to Liuhe, Shuangyang, Changchun, Beijing, Sichuan, Nanchang and other places.
The total area is 1.17 million square meters and the total construction area is 390,000 square meters. The group has 66 wholly-owned subsidiaries with more than 80,000 employees and total assets of 7.5 billion yuan.
Xiu Xiu Pharmaceutical Group was founded in May 1995 by Chairman Xiu Laigui. It integrates the scientific research, production and marketing of patent medicines, chemical pharmaceuticals, and biopharmaceuticals, pharmaceutical chain operations, and standard cultivation of traditional Chinese medicinal materials. A large modern private pharmaceutical enterprise. Xiu Xiu Pharmaceutical has two head offices, three national well-known trademarks "Xu Xiu, Tong Yao and Star Shu", and a development pattern of 14 sales platforms.
Extended information:
By the end of 2016, the group had 127 subsidiaries, more than 100,000 employees, and stock assets of 17 billion yuan. It has 24 dosage forms and more than 2,000 varieties of medicines and health products, including 109 varieties.
More than 50 varieties have sold over 100 million yuan, more than 20 varieties have sold over 1 billion yuan, and more than 50 varieties have development potential. Among them, Feining, Xiaomi Shuan, Liuwei Rehmannia and Jingping have been cultivated through secondary development. There are more than a dozen large-scale products worth more than 500 million yuan, including Yaokang, Yiqi Yangxue, etc.; the use of new formulation technology to develop Starsu pellets and dispersible tablets has ensured Amend's position in the domestic gastric medicine market.
The company has a domestic scientific research system that integrates science and technology management, innovative drug research, and the transformation of new technology achievements. It has more than 300 technical experts, has obtained more than 700 authorized patents, and won 7 national science and technology progress awards. .